Zürcher Nachrichten - Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

EUR -
AED 4.320095
AFN 75.885663
ALL 95.39106
AMD 434.359293
ANG 2.105503
AOA 1079.875165
ARS 1641.608916
AUD 1.626097
AWG 2.117403
AZN 2.00155
BAM 1.955617
BBD 2.368967
BDT 144.323592
BGN 1.962246
BHD 0.444119
BIF 3501.171877
BMD 1.176335
BND 1.49156
BOB 8.128238
BRL 5.776866
BSD 1.176185
BTN 111.070676
BWP 15.79252
BYN 3.324188
BYR 23056.161221
BZD 2.365567
CAD 1.606091
CDF 2724.390954
CHF 0.915576
CLF 0.026587
CLP 1046.373458
CNY 8.005017
CNH 8.000023
COP 4398.19802
CRC 540.701063
CUC 1.176335
CUP 31.172871
CVE 110.244828
CZK 24.30766
DJF 209.470369
DKK 7.473237
DOP 69.953444
DZD 155.593016
EGP 62.020486
ERN 17.645021
ETB 183.670087
FJD 2.570173
FKP 0.864396
GBP 0.864212
GEL 3.152187
GGP 0.864396
GHS 13.250758
GIP 0.864396
GMD 85.872502
GNF 10320.111643
GTQ 8.981158
GYD 246.116934
HKD 9.20856
HNL 31.271069
HRK 7.533241
HTG 154.005567
HUF 356.064543
IDR 20432.346547
ILS 3.416253
IMP 0.864396
INR 111.13652
IQD 1540.955585
IRR 1544409.901346
ISK 143.806836
JEP 0.864396
JMD 185.392625
JOD 0.834004
JPY 184.389884
KES 151.900296
KGS 102.835777
KHR 4719.557692
KMF 492.883828
KPW 1058.643569
KRW 1725.519067
KWD 0.361876
KYD 0.980308
KZT 543.610531
LAK 25796.582394
LBP 105337.827942
LKR 378.68071
LRD 215.849771
LSL 19.297891
LTL 3.473411
LVL 0.711553
LYD 7.437639
MAD 10.757232
MDL 20.115115
MGA 4913.101009
MKD 61.641843
MMK 2469.840437
MNT 4209.987489
MOP 9.484411
MRU 47.016594
MUR 55.076306
MVR 18.180264
MWK 2039.30888
MXN 20.271482
MYR 4.612434
MZN 75.167161
NAD 19.297891
NGN 1599.45028
NIO 43.28208
NOK 10.821804
NPR 177.729344
NZD 1.973736
OMR 0.452335
PAB 1.17629
PEN 4.066656
PGK 5.19405
PHP 71.143536
PKR 327.806219
PLN 4.232417
PYG 7184.685358
QAR 4.299213
RON 5.224695
RSD 117.388809
RUB 87.170473
RWF 1724.438389
SAR 4.447279
SBD 9.448624
SCR 16.852352
SDG 706.388119
SEK 10.84046
SGD 1.491516
SHP 0.878253
SLE 28.944025
SLL 24667.14716
SOS 672.236999
SRD 44.031407
STD 24347.754442
STN 24.495518
SVC 10.292117
SYP 130.036684
SZL 19.285193
THB 37.889551
TJS 10.974871
TMT 4.128935
TND 3.41668
TOP 2.832332
TRY 53.363256
TTD 7.971541
TWD 36.930438
TZS 3063.933249
UAH 51.665846
UGX 4407.193579
USD 1.176335
UYU 46.911416
UZS 14267.389376
VES 583.707963
VND 30947.014765
VUV 138.838256
WST 3.180917
XAF 655.895531
XAG 0.014572
XAU 0.00025
XCD 3.179103
XCG 2.119812
XDR 0.818154
XOF 655.836996
XPF 119.331742
YER 280.672359
ZAR 19.312335
ZMK 10588.444039
ZMW 22.394901
ZWL 378.779312
  • CMSC

    0.0000

    22.97

    0%

  • BCC

    -0.3800

    72.38

    -0.53%

  • AZN

    -0.1900

    182.33

    -0.1%

  • NGG

    0.8300

    86.74

    +0.96%

  • BTI

    0.0700

    58.15

    +0.12%

  • BCE

    -0.1350

    24.435

    -0.55%

  • GSK

    -0.3250

    50.175

    -0.65%

  • RBGPF

    0.0000

    63.18

    0%

  • RIO

    1.9900

    105.1

    +1.89%

  • JRI

    0.0000

    13.15

    0%

  • RELX

    -0.0941

    33.41

    -0.28%

  • CMSD

    -0.0200

    23.4

    -0.09%

  • VOD

    0.4300

    16.12

    +2.67%

  • BP

    -0.1150

    43.695

    -0.26%

  • RYCEF

    -1.0000

    16.45

    -6.08%

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.

Text size:

ATLANTA, GA / ACCESS Newswire / October 23, 2025 / Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational risk management across sponsor study portfolios.

"Florence was built to bring sponsors and sites into a shared operational space," said Ryan Jones, CEO of Florence Healthcare. "First, we fully digitized startup to eliminate manual bottlenecks and paper workflows. Now, we're using AI to enhance speed and augment intelligence across 65,000 study sites globally - arming sponsors with portfolio-wide operational visibility so they can anticipate trial risk, act on insights, and drive execution on the ground."

Solving the $1 million per study problem

While digital-first sites set new standards for operational speed and efficiency, much of the industry still remains offline. Only 30% of global sites currently use an eISF, leaving roughly 200,000 sites dependent on inefficient paper processes for study startup, document collection and storage, regulatory process management, monitoring and closeout.

This lack of digitization costs sponsors an estimated $1 million per study in lost productivity, rework, quality and compliance risk.

Florence is closing this digital divide through the fastest growing clinical research network of 65,000 study sites and 600+ sponsors. By digitizing 100% of operational workflows, Florence sets the standard for startup speed, operational cost reduction, and risk control.

The results are compelling:

  • Up to 70% faster last mile study startup operations compared to the average site startup time for a Top 10 global pharmaceutical sponsor.

  • $141M annual operational cost takeout by automating site readiness workflows, based on active daily users and total hours saved per year across Florence's study site network.

  • 51% increase in eTMF QA pass rates from 65% to 98.7%, due to built-in operational audits and automated compliance checks to control risk.

Shaping the Future of Study Operations

Florence is embedding AI across the study lifecycle to unlock operational data intelligence, recommend next-best actions, strengthen risk control, and improve operating efficiency.

Site Identification & Feasibility

Drawing on the industry's largest network of site intelligence, Florence enables sponsors and CROs to identify the most qualified sites by therapeutic area, geography, and performance, while AI-assisted feasibility surveys ensure faster, more accurate completion.

Study Startup

AI-enabled contracting and document exchange between eTMF and eISF automates SSU document exchange, while generative AI redlining shortens contract review cycles, compares terms in seconds, and dramatically reduces time to activation.

Remote Monitoring

AI-powered reporting surfaces early risk signals from operational audit trails and site data, providing real-time visibility and enabling proactive intervention. These insights minimize the need for on-site visits and ensure trials stay on schedule.

Together, these advancements move sponsors and CROs from manual oversight to intelligent execution across global study portfolios. Through its open API network, Florence rapidly integrates and extends its trial operation capabilities to other eClinical partner systems.

Florence AI operates at the speed of trust, ensuring every study remains fully aligned with FDA, EMA, HIPAA, GDPR, EU Annex 11, ICH E6 (R3), and GCP standards.

All capabilities will be available in December 2025.

Join the Movement: Research Revolution 2025

Florence will showcase its newest capabilities at Research Revolution 2025, the company's annual global event (October 26-28, 2025) bringing together sponsors, CROs, and research sites. Be part of the global revolution. Watch it live at: https://researchrevolutionsummit.com/live/

About Florence Healthcare

Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies-empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.

Contact Information

Seema Sheth-Voss
[email protected]
(888) 829-0896

SOURCE: Florence Healthcare



View the original press release on ACCESS Newswire

W.Odermatt--NZN